Ora Biomedical, Inc.

Company profile

Ora Biomedical, Inc. company profile

Ora Biomedical, Inc. is a new pharmaceutical company launched out of the Kaeberlein Lab at the University of Washington. We built a high-throughput small molecule discovery platform to identify longevity interventions, including natural products, pharmaceuticals, and small molecule combinations at a previously unimagined scale. The foundation of our platform is the WormBot-AI, a robotic system coupled with AI-powered analytics to perform phenotype-based screens in live animals. The WormBot-AI is robust, stable, scalable, and already in use identifying novel interventions and aging targets. Ora Biomedical holds the exclusive commercial use rights to the WormBot platform and AI software.